PHVS – pharvaris n.v. - ordinary shares (US:NASDAQ)
Stock Stats
News
Pharvaris (NASDAQ:PHVS) had its "buy" rating reaffirmed by analysts at Guggenheim.
Pharvaris (NASDAQ:PHVS) had its "outperform" rating reaffirmed by analysts at Oppenheimer Holdings, Inc..
Pharvaris (NASDAQ:PHVS) had its price target raised by analysts at Bank of America Corporation from $27.00 to $30.00. They now have a "neutral" rating on the stock.
Pharvaris (PHVS) Is Up 5.9% After Phase 3 RAPIDe-3 Win - Has The Bull Case Changed? [Yahoo! Finance]
Pharvaris (NASDAQ:PHVS) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Form 144 Pharvaris N.V. Filed by: Abele Stefan Andreas
Form 144 Pharvaris N.V. Filed by: Schikan Johannes Gerardus Christiaan Petrus
Form 144 Pharvaris N.V. Filed by: Modig Berndt
Form 6-K Pharvaris N.V. For: Dec 03
Form SCHEDULE 13G/A Pharvaris N.V. Filed by: Bain Capital Life Sciences Fund, L.P.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.